SURGERY CAN BE AVOIDED IN EXTRA OCULAR AND ORBITAL MYOCYSTICERCOSIS
Abstract
Aim: To study the efficacy of Albendazole in treating Extra ocular and Orbital Myocysticercosis.
Materials and Methods: This is a prospective interventional case study conducted at Department of Oculoplasty and Orbital disorder of Sarojini Devi Eye Hospital which is a tertiary care eye hospital. 6 cases of Myocysticercosis, 4 males and 2 females presented between Jan 2014 to June 2014 at department of Oculoplasty were included in the study. After clinical examination and radiological confirmation patients were given oral Albendazole 400mg bd for 3 weeks along with Tab.Prednisolone 1mg /Kg of body weight. They were evaluated clinically for control of symptoms like pain, redness and protrusion of eyeball and regression of signs like reduction in chemosis, Proptosis and tenderness.
Results: All 6 cases responded to medical treatment by Albendazole and Prednisolone by total reduction in symptoms and signs thereby avoiding surgery on them.
Conclusion: Ocular and Orbital Myocysticercosis respond well to medical treatment by Tab.Albendazole along with Tab. Prednisolone.
Key Words: Myocysticercosis, Albendazole, Proptosis, Prednisolone.Keywords:
Myocysticercosis, Albendazole, Proptosis, Prednisolone.DOI
https://doi.org/10.22270/jddt.v5i2.1083References
Text book of parasitology by K D Chaterjee,CBS publishers, 13th edition 2009,pages154-155
Murthy GR et al Sub conjunctival cysticercosis, Indian journal of Ophthalmology, July 1986,28(2) 77-78
Rath S et al Orbital cercosis, Ophthalmology,March 2010,117(3) 600-605
R.Shihota, Honavar et al Management of Extra ocular Cysticercosis, BJO Aug. 1994,78(8) 621-623
Puri p, Grover AK et al Medical management of Myocysticercosis, Eye(London)1998, 12 (pt5) 795-799
MehulDamani et al a case report, Saudi journal of Ophthalmology Oct-Dec 2012 Vol 26(4), 457-458
Published
Abstract Display: 533 
PDF Downloads: 721 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.